Related Experiment Video
Updated: May 29, 2025

A Microfluidic Approach for the Study of Ice and Clathrate Hydrate Crystallization
Published on: August 18, 2022
Carbonic anhydrase inhibitors: Structural insights and therapeutic potential
Priti Singh1, Mohammed Arifuddin2, Claudiu T Supuran3
1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500 037, India.
None:
Carbonic anhydrase inhibitors (CAIs) have garnered significant attention in recent years due to their critical role in managing various diseases, including glaucoma, epilepsy, cancer, and other conditions linked to carbonic anhydrase (CA) isoforms. This review highlights the recent advancements in the design and development of CAIs, focusing on diverse chemical classes such as indoles, sulfocoumarins, 1,2,3-triazoles, urea derivatives, chalcones, quinolines, and pyridines. Each class presents unique structural features and mechanisms of action, contributing to the selective inhibition of specific CA isoforms. The ongoing exploration of these compounds has not only enhanced our understanding of CA inhibition but also opened new avenues for therapeutic applications, paving the way for the development of novel drugs that tackle pressing healthcare challenges.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Thiazide-Class Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Aldehydes and Ketones with HCN: Cyanohydrin Formation Overview
Antihypertensive Drugs: Potassium-Sparing Diuretics

